A single-arm, open-label, phase 2 study evaluating pacritinib for patients with biochemical recurrence after definitive treatment for prostate cancer: Blast study.

被引：0
|
作者：
Kilari, Deepak
Szabo, Aniko
Hall, William A.
Nelson, Ariel Ann
Johnson, Scott
Giever, Thomas A.
Burfeind, John
Tolat, Parag
Bylow, Kathryn A.
Iczkowski, Kenneth
Sun, Yunguang
Rui, Hallgeir
Thomas, James P.
Nevalainen, Marja
机构：
[1] Med Coll Wisconsin, Froedtert Canc Ctr, Dept Med, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 06期
关键词：
D O I：
10.1200/JCO.2022.40.6_suppl.TPS220
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS220
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Single-arm, open-label, phase II study of LY3023414 for the treatment of recurrent or persistent endometrial cancer
    Rubinstein, Maria M.
    Hyman, David
    Caird, Imogen
    O'Cearbhaill, Roisin
    Grisham, Rachel
    Tew, William
    Hensley, Martee
    Sabbatini, Paul
    Aghajanian, Carol
    Iasonos, Alexia
    Won, Helen
    Selcuklu, Duygu
    Zimel, Catherine
    Makker, Vicky
    MOLECULAR CANCER RESEARCH, 2020, 18 (10) : 50 - 50
  • [22] A phase II, open-label, single-arm, efficacy, and safety study of MDV3100 in patients with hormone-naive prostate cancer
    Baskin-Bey, E. S.
    Holtkamp, G. M.
    Smith, M. R.
    Ouatas, T.
    Phung, D.
    Tombal, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [23] A SINGLE-ARM, OPEN-LABEL, PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF ABEMACICLIB IN PATIENTS WITH RECURRENT OLIGODENDROGLIOMA: TRIALS IN PROGRESS
    Bagley, Stephen
    Nasrallah, MacLean
    O'Rourke, Donald
    Hussain, Jasmin
    Maloney-Wilensky, Eileen
    Prior, Timothy
    Brem, Steven
    Desai, Arati
    NEURO-ONCOLOGY, 2019, 21 : 219 - 219
  • [24] Molidustat for the treatment of anemia in Japanese patients undergoing peritoneal dialysis: a single-arm, open-label, phase 3 study
    Akizawa, Tadao
    Nobori, Kiyoshi
    Matsuda, Yoshimi
    Taki, Kentaro
    Hayashi, Yasuhiro
    Hayasaki, Takanori
    Yamamoto, Hiroyasu
    THERAPEUTIC APHERESIS AND DIALYSIS, 2022, 26 (02) : 368 - 377
  • [25] Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis
    Brastianos, Priscilla K.
    Lee, Eudocia Quant
    Cohen, Justine V.
    Tolaney, Sara M.
    Lin, Nancy U.
    Wang, Nancy
    Chukwueke, Ugonma
    White, Michael D.
    Nayyar, Naema
    Kim, Albert
    Alvarez-Breckenridge, Christopher
    Krop, Ian
    Mahar, Maura Keeley
    Bertalan, Mia S.
    Shaw, Brian
    Mora, Joana L.
    Goss, Nathaniel
    Subramanian, Megha
    Nayak, Lakshmi
    Dietrich, Jorg
    Forst, Deborah A.
    Nahed, Brian V.
    Batchelor, Tracy T.
    Shih, Helen A.
    Gerstner, Elizabeth R.
    Moy, Beverly
    Lawrence, Donald
    Giobbie-Hurder, Anita
    Carter, Scott L.
    Oh, Kevin
    Cahill, Daniel P.
    Sullivan, Ryan J.
    NATURE MEDICINE, 2020, 26 (08) : 1280 - +
  • [26] Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer
    Wirth, Lori J.
    Brose, Marcia S.
    Sherman, Eric J.
    Licitra, Lisa
    Schlumberger, Martin
    Sherman, Steven, I
    Bible, Keith C.
    Robinson, Bruce
    Rodien, Patrice
    Godbert, Yann
    De La Fouchardiere, Christelle
    Newbold, Kate
    Nutting, Christopher
    Misir, Soamnauth
    Xie, Ran
    Almonte, Ana
    Ye, Weifei
    Cabanillas, Maria E.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (21) : 2359 - +
  • [27] Apremilast for Discoid Lupus Erythematosus: Results of a Phase 2, Open-Label, Single-Arm, Pilot Study
    De Souza, Aieska
    Strober, Bruce E.
    Merola, Joseph F.
    Oliver, Stephen
    Franks, Andrew G., Jr.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2012, 11 (10) : 1224 - 1226
  • [28] Anlotinib combined with pemetrexed as a further treatment of patients with platinum-resistant ovarian cancer: A single-arm, open-label, phase II study
    Gaillard, Stephanie
    Duska, Linda
    Broadwater, Gloria
    McNally, Leah
    Lee, Paula
    Davidson, Brittany
    Previs, Rebecca
    Moss, Haley
    Berchuck, Andrew
    Nixon, Andrew
    Yi, John
    Bookman, Michael
    Secord, Angeles Alvarez
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S61 - S62
  • [29] Everolimus (EVE) for relapsed/refractory classical Hodgkin lymphoma (cHL): Open-label, single-arm, phase II study.
    Johnston, Patrick B.
    Pinter-Brown, Lauren C.
    Rogerio, Jaqueline Willemann
    Warsi, Ghulam
    Chau, Quincy
    Ramchandren, Rod
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [30] Treatment with PBI-4050 in patients with Alstrom syndrome: study protocol for a phase 2, single-Centre, single-arm, open-label trial
    Baig, Shanat
    Veeranna, Vishy
    Bolton, Shaun
    Edwards, Nicola
    Tomlinson, Jeremy W.
    Manolopoulos, Konstantinos
    Moran, John
    Steeds, Richard P.
    Geberhiwot, Tarekegn
    BMC ENDOCRINE DISORDERS, 2018, 18
12345